Emerging research from Australian scholars has unearthed troubling evidence suggesting that vaping may significantly elevate the risk of lung and oral cancers. The comprehensive review conducted by the University of New South Wales highlights early biological indicators of cancer, including DNA damage and inflammation, urging immediate regulatory measures rather than waiting for conclusive long-term studies.
Vaping and Its Biological Implications
The recent study, published in the journal *Carcinogenesis*, represents one of the most extensive evaluations to date regarding the carcinogenic potential of nicotine e-cigarettes. Researchers examined numerous reviews, animal studies, and human case reports from 2017 to 2025, drawing connections between vaping and harmful changes in the body. Co-author Adjunct Professor Bernard Stewart noted, “There is no doubt that the cells and tissues of the oral cavity, the mouth, and the lungs are altered by inhalation from e-cigarettes.”
Despite the popularity of vaping as a perceived safer alternative to smoking, there is an evident lack of long-term data to adequately assess its risks. Since e-cigarettes were introduced in the early 2000s, the absence of extensive longitudinal studies hampers the ability to draw definitive conclusions about their cancer-causing potential. This gap in research is exacerbated by the fact that many individuals who vape also smoke, complicating the isolation of vaping’s specific effects.
Evidence from Case Reports and Animal Studies
While the review did not attempt to quantify how many individuals may develop cancer as a result of vaping, it did examine alarming case reports from dental professionals who have observed oral cancers in individuals who only vaped and had never smoked. Additionally, animal studies referenced in the review indicated that mice exposed to e-cigarette vapour experienced a higher incidence of lung tumours compared to their unexposed counterparts. Although such findings do not directly translate to human health risks, they are concerning enough to warrant heightened scrutiny.
The lead author, Associate Professor Freddy Sitas, stressed the importance of acting on current evidence rather than waiting for overwhelming consensus, pointing to the historical example of smoking’s recognition as a cause of lung cancer. “It took 100 years of emerging evidence before the US Surgeon General acknowledged smoking as a major cause of lung cancer in 1964,” Sitas remarked.
A Call for Immediate Action
Calvin Cochran, a public health research fellow at the University of Otago, cautioned that dismissing early warning signs of harm from vaping could lead to a repeat of the historical missteps associated with tobacco use. “Every study like this should be considered seriously by policymakers, governments, and health organisations. We risk repeating the same fate with vaping if we do not take emerging research seriously,” he stated.
Despite the prevailing assumption that vaping is a safer alternative to smoking, the accumulating evidence suggests otherwise. “We’ve always assumed that vapes are safer than cigarettes, but we now need to question that assumption,” Sitas added. The researchers emphasised the necessity for regulators to act decisively to protect vulnerable populations, particularly children, from the potential dangers of vaping.
Perspectives on Risk Comparisons
While some experts caution against equating vaping with smoking due to the absence of combustion-related toxins in e-cigarettes, the argument for assessing vaping’s independent health risks remains compelling. Professor Stephen Duffy from Queen Mary University in London noted that it would be an “overinterpretation” to categorically state vaping is as harmful as smoking. However, Stewart maintained that it is crucial to evaluate the potential for e-cigarettes to cause cancer on their own merits.
Professor Becky Freeman, a tobacco control researcher at the University of Sydney, underscored the study’s significance, asserting that it is the first to suggest a likely increased cancer risk for vapers compared to non-vapers. “This information is particularly important for young people who have never smoked,” she stated, reinforcing the notion that vaping should not be viewed as a safe alternative for non-smokers.
Why it Matters
The implications of this research are profound. As vaping continues to gain popularity, particularly among younger demographics, the potential health risks associated with these products cannot be overlooked. With evidence mounting that suggests significant cancer risks linked to vaping, it is imperative for regulatory bodies to take decisive action. Protecting public health, especially that of children and non-smokers, must remain a priority as we confront the evolving landscape of nicotine consumption. It is essential that we learn from the past and adopt a proactive stance on emerging threats to health, rather than waiting for a crisis to unfold.
